nitrendipine has been researched along with Atrial Fibrillation in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gaspo, R | 1 |
Sun, H | 1 |
Fareh, S | 1 |
Levi, M | 1 |
Yue, L | 1 |
Allen, BG | 1 |
Hebert, TE | 1 |
Nattel, S | 1 |
1 other study available for nitrendipine and Atrial Fibrillation
Article | Year |
---|---|
Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atrial Fibrillation; Binding Sites; Calc | 1999 |